About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Prospective Use of Awake Endoscopy for Inspire Activation

NCT03990298·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Pennsylvania

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients with moderate to severe OSA who have undergone Inspire UAS implantation by the principal investigator
Must have symptoms of OSA prior to Inspire implantation
AHI between 15 and 65, where central and mixed apnea is 25% or more, and the level of collapse is in the soft palate area BMI less than 32
Age 18 or above

You may not be if

Significant central sleep apnea
Presence of other sleep disorders
History of neurologic or neuromuscular disease
Historical or present substance abuse
Bleeding disorders
Autoimmune diseases that increase risk of nasal trauma such as Wegener's, Sarcoidosis, etc.
Pregnancy

The record

StatusCompleted

PhaseNo phase

Taking part16

StartedNov 2018

UpdatedAug 4, 2021

Conditions

Obstructive Sleep Apnea

Where1

Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States

Clareo Health | Prospective Use of Awake Endoscopy for Inspire Activation